Feng Chi Biotech Corp. (TPEX:6744)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
17.50
0.00 (0.00%)
At close: Feb 11, 2026

Feng Chi Biotech Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
15.6416.5922.7924.6123.1425.39
Depreciation & Amortization
11.069.227.216.318.89.89
Loss (Gain) From Sale of Assets
-----0.2-
Other Operating Activities
-0.38-1.28-0.730.41-0.61-0.08
Change in Accounts Receivable
-0.13-0.93-3.860.340.731.32
Change in Inventory
-11.74-0.01-1.54-8.591.43-6.04
Change in Accounts Payable
4.454.12-5.733.770.722.47
Change in Unearned Revenue
3.97-1.89-1.071.27-0.833.52
Change in Other Net Operating Assets
-5.77-0.79-1.660.36-0.252.81
Operating Cash Flow
17.0925.0515.4228.4932.9339.29
Operating Cash Flow Growth
-8.05%62.50%-45.90%-13.47%-16.19%66.41%
Capital Expenditures
-24.53-14.59-1.4-0.09-1.1-3.07
Sale of Property, Plant & Equipment
----0.2-
Sale (Purchase) of Intangibles
-0.04---0.17--
Investment in Securities
1.554.4-27.5212.47-9.49-12.51
Other Investing Activities
-0.32-0.41.58-1.59-0.59-0.16
Investing Cash Flow
-23.34-10.6-27.3410.62-10.97-15.75
Long-Term Debt Repaid
--2.65-2.58-2.76-2.71-2.64
Net Debt Issued (Repaid)
-2.69-2.65-2.58-2.76-2.71-2.64
Common Dividends Paid
-16.17-16.17-20.79-19.25-17.71-13.86
Financing Cash Flow
-18.86-18.82-23.37-22.01-20.42-16.5
Net Cash Flow
-25.11-4.37-35.2917.11.537.04
Free Cash Flow
-7.4410.4614.0228.431.8336.22
Free Cash Flow Growth
--25.42%-50.63%-10.78%-12.12%88.79%
Free Cash Flow Margin
-4.14%6.11%7.76%14.68%17.43%20.24%
Free Cash Flow Per Share
-0.480.680.911.842.062.34
Cash Interest Paid
0.220.250.330.060.10.17
Cash Income Tax Paid
2.925.025.245.395.544.51
Levered Free Cash Flow
-14.793.3914.9523.730.7429.4
Unlevered Free Cash Flow
-14.653.5415.1523.7330.829.5
Change in Working Capital
-9.230.52-13.86-2.851.84.08
Source: S&P Global Market Intelligence. Standard template. Financial Sources.